Unilife has initiated US production of the Unitract 1ml Insulin Syringe at its FDA-registered manufacturing facility in Pennsylvania. The company claims, this milestone follows the successful transfer of
Cannabis Science has completed its review of the FDA licensing requirements and has made key progress with mapping out its initial cannabis drug medicines for FDA clinical trials.
Neurobiological Technologies (NTI) has entered into an agreement to terminate its license and cooperation agreement with Merz Pharmaceuticals (Merz) and Children’s Medical Center Corporation (CMCC). Pursuant to the
Schering-Plough has launched ClaritinEye, an antihistamine eye drop, for control of itchy eyes. The company claims that ClaritinEye, an over-the-counter product, works in minutes to relieve the itch
The FDA has published two rules that seek to clarify the methods available to seriously ill patients interested in gaining access to investigational drugs and biologics when they
Light Sciences Oncology (LSO) has reported the treatment of the first patient in phase 1 pediatric study of its novel light-activated drug Aptocine (talaporfin sodium) in neurofibromatosis type
Ranbaxy has launched its protein supplement under the brand name, Revitalite, marking its entry into the protein supplements market in India. The company claims that Revitalite offers a
Exact Sciences reported total revenues of $1.3m for the second quarter of 2009, compared to total revenues of $146,000 during the same period of 2008. Total revenues for
Accera has announced that data showed that using ketone bodies can be an effective and safe method to approach Alzheimer’s Disease. The results were published as scientific paper
Bristol-Myers Squibb has reported the expiration of Hart-Scott-Rodino (HSR) review period for its tender offer for Medarex. The expiration of the HSR waiting period satisfies one of the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.